BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 17924986)

  • 1. Combining dialysate and blood recirculation to boost uremic toxin removal: theory and simulation study.
    Prado M; Roa L
    Artif Organs; 2007 Dec; 31(12):895-901. PubMed ID: 17924986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemodialysis with on-line monitoring equipment: tools or toys?
    Locatelli F; Buoncristiani U; Canaud B; Köhler H; Petitclerc T; Zucchelli P
    Nephrol Dial Transplant; 2005 Jan; 20(1):22-33. PubMed ID: 15632348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving hollow fiber dialyzer efficiency with a recirculating dialysate system II: comparison against two-chamber dialysis systems.
    Prado M; Roa LM; Palma A; Milán JA
    Ann Biomed Eng; 2005 Nov; 33(11):1595-606. PubMed ID: 16341926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodialysis blood access flow rates can be estimated accurately from on-line dialysate urea measurements and the knowledge of effective dialyzer urea clearance.
    Lindsay RM; Sternby J; Olde B; Persson R; Thatcher ME; Sargent K
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):960-4. PubMed ID: 17699313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Online hemodiafiltration.
    Van Laecke S; De Wilde K; Vanholder R
    Artif Organs; 2006 Aug; 30(8):579-85. PubMed ID: 16911311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Problems and solutions for artificial kidney.
    Vanholder R
    Technol Health Care; 2000; 8(6):373-9. PubMed ID: 11258583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dialyzer clearances and mass transfer-area coefficients for small solutes at low dialysate flow rates.
    Leypoldt JK; Kamerath CD; Gilson JF; Friederichs G
    ASAIO J; 2006; 52(4):404-9. PubMed ID: 16883120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should dialysis modalities be designed to remove specific uremic toxins?
    Baurmeister U; Vienken J; Ward RA
    Semin Dial; 2009; 22(4):454-7. PubMed ID: 19709001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing dialysate flow rate increases dialyzer urea clearance and dialysis efficiency: an in vivo study.
    Azar AT
    Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):1023-9. PubMed ID: 19861865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing the removal of protein-bound uremic toxins by liposome-supported hemodialysis.
    Shi Y; Wang Y; Ma S; Liu T; Tian H; Zhu Q; Wang W; Li Y; Ding F
    Artif Organs; 2019 May; 43(5):490-503. PubMed ID: 30375673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uremic toxins: a new focus on an old subject.
    Yavuz A; Tetta C; Ersoy FF; D'intini V; Ratanarat R; De Cal M; Bonello M; Bordoni V; Salvatori G; Andrikos E; Yakupoglu G; Levin NW; Ronco C
    Semin Dial; 2005; 18(3):203-11. PubMed ID: 15934967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Renal replacement therapy by hemodialysis: an overview].
    Jacobs C
    Nephrol Ther; 2009 Jul; 5(4):306-12. PubMed ID: 19481513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new synthetic dialyzer with advanced permselectivity for enhanced low-molecular weight protein removal.
    Krieter DH; Lemke HD; Wanner C
    Artif Organs; 2008 Jul; 32(7):547-54. PubMed ID: 18638309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Middle molecule removal in low-flux polysulfone dialyzers: impact of flows and surface area on whole-body and dialyzer clearances.
    Eloot S; de Vos JY; de Vos F; Hombrouckx R; Verdonck P
    Hemodial Int; 2005 Oct; 9(4):399-408. PubMed ID: 16219061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temperature and concentration distribution within the Genius dialysate container.
    Eloot S; Dhondt A; Vierendeels J; De Wachter D; Verdonck P; Vanholder R
    Nephrol Dial Transplant; 2007 Oct; 22(10):2962-9. PubMed ID: 17567650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on dialysate mixing in the Genius single-pass batch system for hemodialysis therapy.
    Dhondt AW; Vanholder RC; De Smet RV; Claus SA; Waterloos MA; Glorieux GL; Delanghe JR; Lameire NH
    Kidney Int; 2003 Apr; 63(4):1540-7. PubMed ID: 12631371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Removal of uraemic retention solutes in standard bicarbonate haemodialysis and long-hour slow-flow bicarbonate haemodialysis.
    Basile C; Libutti P; Di Turo AL; Casino FG; Vernaglione L; Tundo S; Maselli P; De Nicolò EV; Ceci E; Teutonico A; Lomonte C
    Nephrol Dial Transplant; 2011 Apr; 26(4):1296-303. PubMed ID: 20813765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Depurative efficiency of intermediate and large molecules with different hemodialysis modalities].
    Maduell F
    Nefrologia; 2005; 25 Suppl 2():15-8. PubMed ID: 16050396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. More of the same: improving outcomes through intensive hemodialysis.
    McFarlane PA
    Semin Dial; 2009; 22(6):598-602. PubMed ID: 20017828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.